Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALBAVANCIN vs ORITAVANCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DALBAVANCIN vs ORITAVANCIN: Safety Overview

Metric DALBAVANCIN ORITAVANCIN
Total FAERS Reports 1,107 884
Deaths Reported 54 29
Death Rate 4.9% 3.3%
Hospitalizations 288 157
Average Patient Age 61.0 yrs 55.9 yrs
% Female Patients 46.7% 52.2%
FDA Approval Date May 23, 2014 N/A
Manufacturer Fresenius Kabi USA, LLC Melinta Therapeutics, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A